Overview

Collate provides AI-driven solutions to simplify and enhance the documentation process for companies involved in diagnostics, medical devices, and drug development. Their product automates the creation of essential paperwork needed throughout the development cycle, from initial concept to market launch. This automation helps ensure that the documentation is accurate and compliant with industry standards. What sets Collate apart from its competitors is its focus on the life sciences sector, specifically tailoring its services to meet the unique needs of this industry. The primary goal of Collate is to speed up the introduction of life-saving innovations by making the documentation process more efficient.

💡 Want to apply to Collate?

You have ways to get a Collate referral from your network.

Get referrals →

Simplify's Take

What believers are saying

• Collate secured $30M in funding, indicating strong investor confidence and market potential.
• There's a growing demand for AI-driven automation in life sciences to enhance R&D efficiency.
• Potential partnerships with biotech firms could expand Collate's market reach and integration.

What critics are saying

• Competition from established AI automation companies like UiPath and Automation Anywhere is increasing.
• Ethical and regulatory challenges in automating sensitive medical documentation could arise.
• Rapid AI advancements may render Collate's solutions obsolete without continuous innovation.

What makes Collate unique

• Collate focuses on automating paperwork in the life sciences industry using AI.
• The company is led by experienced founders Surbhi Sarna, Nate Smith, and Jigish Patel.
• Collate targets diagnostic, medical device, and drug development companies for streamlined documentation.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$30M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:

Y Combinator

Notable Investors:

Y Combinator

$30,000,000

Seed

Jan 2025

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.

Seed Funding Comparison

Above Average

Industry standards

Ind Avg. $3.3M

$500k

$1.5M

$2M

$2.3M

$3M

$30M